{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Fayetteville",
      "state": "AR",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "96706",
      "recalling_firm": "OurPharma LLC",
      "address_1": "2512 S City Lake Rd",
      "address_2": "N/A",
      "postal_code": "72701-5013",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0385-2025",
      "product_description": "HYDROmorphone Hydrochloride 50mg/50mL (1mg/mL), packaged in a 50 mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, AR 72701,  NDC 73013-1040-01.",
      "product_quantity": "1,375 cassettes",
      "reason_for_recall": "Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..",
      "recall_initiation_date": "20250415",
      "center_classification_date": "20250421",
      "termination_date": "20260306",
      "report_date": "20250430",
      "code_info": "104024120001, Exp Date 06/01/2025; 104024120002, Exp Date 06/21/2025; 104025010001, Exp Date 07/13/2025; 104025010002, Exp Date 07/28/2025"
    }
  ]
}